NBT Bancorp (NBTB) Q3 2025 earnings summary

Executive summary

• Achieved record Q3 2025 net income of $54.5 million and diluted EPS of $1.03, up significantly year-over-year and sequentially, driven by strong operating leverage, asset repricing, and the Evans Bancorp acquisition.

• Completed the Evans Bancorp acquisition in May 2025, adding $1.67 billion in loans, $1.86 billion in deposits, and expanding into key New York markets.

• Tangible book value per share rose 7% year-over-year to $25.51, exceeding pre-merger levels.

• Declared a quarterly cash dividend of $0.37 per share, up 8.8% year-over-year, marking the thirteenth consecutive annual increase.

• Operating return on assets was 1.37%, return on equity 12.1%, and ROTCE 17.6%, all improved year-over-year and sequentially.

Financial highlights

• Net income for Q3 2025 was $54.5 million, or $1.03 per diluted share; operating EPS was $1.05, up $0.17 from the prior quarter.

• Net interest income was $134.7 million, up $10 million from Q2 and $33 million from Q3 2024; net interest margin increased for the sixth consecutive quarter to 3.66%.

• Noninterest income was $51.4 million, 28% of total revenues, up 9.8% sequentially and 13.5% year-over-year.

• Total loans at period end were $11.60 billion, up $1.63 billion from December 2024; deposits reached $13.66 billion, up $2.11 billion from December 2024.

• Allowance for loan losses was $139.0 million, or 1.20% of total loans; nonperforming loans to total loans stood at 0.46%.

Outlook and guidance

• Cost saves from the Evans merger are essentially achieved; $110 million quarterly expense run rate expected to continue, with typical annual increases of 3.5%-4.5%.

• Loan growth expected in the low to mid-single digits into early/mid-2026, with robust pipelines but higher payoffs than anticipated.

• Margin may face short-term pressure due to potential Fed rate cuts, but could improve in 2026 if the yield curve steepens; net interest income trajectory will depend on interest rate movements.

• Fee income, especially insurance, expected to grow at high mid-single digits annually; Q4 typically 6%-8% lower than Q3 due to seasonality.

• Board authorized an amendment to the stock repurchase program, allowing up to 2 million shares to be repurchased by December 31, 2027.